Does there exist a subgroup of MB patients at greater risk of relapse after MDT?
Baohong
J
J
D004359:Drug Therapy, Combination; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000517:prevention & control*; D012008:Recurrence
D007917:Leprostatic Agents